Resources Jobs
Postings are free of charge for announcements or services provided by nonprofit institutions. There may be fee for postings by for-profit entities. Posting is at the discretion of the Society for Glycobiology. Email us with full text to post.
Posted: April 8, 2019
Research Scientists at GlycoBac
Dr. Donald Jarvis is seeking two motivated individuals to serve as Research Scientists at GlycoBac, LLC  (, a small biotechnology company created in 2011. GlycoBac’s primary mission is to refine and commercialize improved baculovirus-insect cell platforms for recombinant protein and biologics production. One major effort focuses on glycoengineered baculovirus vectors and insect cell lines originally developed in Dr. Jarvis’ academic labs at Texas A&M University and the University of Wyoming ( Refinement of these tools will yield new expression systems that can be used to manufacture recombinant glycoproteins with specific, pre-selected glycosylation profiles, including humanized profiles, that enhance their properties. Another major effort focuses on a current product already developed by GlycoBac, which is a virus-free insect cell line (Spodoptera frugiperda rhabdovirus negative; Sf-RVN). In a key partnership with MilliporeSigma, we are licensing Sf-RVN cells for use in biologics manufacturing. In addition, we are using Sf-RVN cells for Sf-rhabdovirus infectivity assays designed to detect contamination in insect cell lines use for and materials produced in insect cell-based manufacturing processes.